Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-05-03 00:00:00 ET · period of report 2022-05-01 · accession 0000899243-22-016384 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-03 | 2022-05-01 | VRTX | Kearney Terrence C | Dir | A - Grant | $0.00 | +725 | 6,536 | +12% | $0 |
| D | 2022-05-03 | 2022-05-01 | VRTX | Kearney Terrence C | Dir | A - Grant | $0.00 | +2,231 | 2,231 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-01 | A | A | 725 | $0.00 | 6,536 | D | — | — | (F1) Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-05-01 | A | A | 2,231 | $0.00 | 2,231 | D | $276.17 · 2022-05-01 to 2032-04-30 | 2,231 Common Stock |